Physician profile
Katherine Chen
NPI 1780927491
$1,940.65
in general payments reported to CMS, 2019-2025
5 companies · $1,500 in 2025
The $1,500 reported for 2025 was more than what 90% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $248 · 2023: $21.73 · 2024: $172 · 2025: $1,500.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $887 · Food and Beverage: $806.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $887.11 |
| Food and Beverage | $805.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $1,468.51 | 2025 | |
| Glaxosmithkline, LLC. | $247.56 | 2022 | |
| Inari Medical, INC. | $171.77 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $31.08 | 2025 | Caplyta |
| Astellas Pharma US INC | $21.73 | 2023 | Veozah |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.